Ibogaine neurotoxicity assessment: electrophysiological, neurochemical, and neurohistological methods.
Binienda
Z K
ZK
Division of Neurotoxicology, FDA/National Center for Toxicological Research, Jefferson, AR 72079-9502, USA.
Scallet
A C
AC
Schmued
L C
LC
Ali
S F
SF
D000818:Animals; D001921:Brain / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D004569:Electroencephalography / Q000187:drug effects; D016762:Genes, fos; D006801:Humans; D007050:Ibogaine / Q000633:toxicity*; D018377:Neurotransmitter Agents / Q000378:metabolism
D018377:Neurotransmitter Agents; D007050:Ibogaine